Yoshie Yoshikawa
6638501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 13, 2026
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 13, 2025
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 11, 2024
BAP1 depletion in human B-lymphoblast cells affects the production of innate immune cytokines and chemokines.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: August 01, 2022
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 15, 2021
Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification.
Journal: Cancer science
Published: June 18, 2021
Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 15, 2020
Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years.
Journal: Pathology international
Published: July 01, 2020
Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment.
Journal: Frontiers in oncology
Published: April 22, 2020
Mesothelioma developing in carriers of inherited genetic mutations.
Journal: Translational lung cancer research
Published: March 25, 2020
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 31, 2018
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 12, 2016
Last Updated: 09/26/2026